Developing an evaluation model to support evidence-based decision-making on provincial vaccination program of Zhejiang province

References

[1] Oliveira CR, Avni-Singer L, Badaro G, Sullivan EL, Sheth SS, Shapiro ED, et al. Feasibility and accuracy of a computer-assisted self-interviewing instrument to ascertain prior immunization with human papillomavirus vaccine by self-report: Cross-sectional analysis. JMIR Med Inform 2020; 8(1): e16487.

[2] Chen F, Pan X, Liang H, Shen L, Wang Y, Chen Y, et al. Real-world safety profile of the 9-valent human papillomavirus vaccine: A study in Zhejiang, China from 2019 to 2021. Hum Vaccin Immunother 2022; 18(7): 2152256.

[3] Erickson LJ, De Wals P, Farand L. An analytical framework for immunization programs in Canada. Vaccine 2005; 23: 2468-2474.

[4] MacDonald N, Embree J. Access to vaccines: A call to action. Can J Infect Dis 2003; 14: 9-10.

[5] Tapia-Conyer R, Betancourt-Cravioto M, Saucedo-Martínez R, Motta-Murguía L, Gallardo-Rincón H. Strengthening vaccination policies in Latin America: An evidence-based approach. Vaccine 2013; 31(37): 3826-3833.

[6] Hubble MW, Renkiewicz GK. Estimated cost effectiveness of influenza vaccination for emergency medical services professionals. West J Emerg Med 2021; 22(6): 1317-1325.

[7] Anderson R, Kim S, Roberts N, Petrou S. Systematic review of economic evaluations of varicella vaccination programmes. PLoS One 2023; 18(3): e0282327.

[8] Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2018; 2(2): CD004879.

[9] Alghounaim M, Alsaffar Z, Alfraij A, Bin-Hasan S, Hussain E. Whole-cell and acellular pertussis vaccine: Reflections on efficacy. Med Princ Pract 2022; 31(4): 313-321.

[10] Shukla VV, Shah RC. Vaccinations in primary care. Indian J Pediatr 2018; 85(12): 1118-1127.

[11] Cohen JUS. Vaccine supply falls seriously short. Science 2002; 295: 1998-2001.

[12] Chowdhury P, Paul SK, Kaisar S, Moktadir MA. COVID-19 pandemic related supply chain studies: A systematic review. Transp Res E Logist Transp Rev 2021; 148: 102271.

[13] Rockwell PG. ACIP approves 2023 child/adolescent and adult immunization schedules. Am Fam Physician 2023; 107(3): 319-322.

[14] Nachbagauer R, Palese P. Is a universal influenza virus vaccine possible? Annu Rev Med 2020; 71: 315-327.

[15] Tanner AR, Dorey RB, Brendish NJ, Clark TW. Influenza vaccination: Protecting the most vulnerable. Eur Respir Rev 2021; 30(159): 200258.

[16] Favato G, Easton T, Vecchiato R, Noikokyris E. Ecological validity of cost-effectiveness models of universal HPV vaccination: A systematic literature review. Vaccine 2017; 35(20): 2622-2632.

[17] Dubé È, Ward JK, Verger P, MacDonald NE. Vaccine hesitancy, acceptance, and anti-vaccination: Trends and future prospects for public health. Annu Rev Public Health 2021; 42: 175-191.

[18] Green MS. Rational and irrational vaccine hesitancy. Isr J Health Policy Res 2023; 12(1): 11.

[19] Phadke VK, Bednarczyk RA, Salmon DA, Omer SB. Association between vaccine refusal and vaccine-preventable diseases in the United States: A review of measles and pertussis. JAMA 2016; 315(11): 1149-1158.

[20] Salman O, Topf K, Chandler R, Conklin L. Progress in immunization safety monitoring-worldwide, 2010-2019. MMWR Morb Mortal Wkly Rep 2021; 70(15): 547-551.

[21] Bauwens J, de Lusignan S, Weldesselassie YG, Sherlock J, Künzli N, Bonhoeffer J. Safety of routine childhood vaccine coadministration versus separate vaccination. BMJ Glob Health 2022; 7(9): e008215.

[22] Bauwens J, de Lusignan S, Sherlock J, Ferreira F, Künzli N, Bonhoeffer J. Co-administration of routine paediatric vaccines in England often deviates from the immunisation schedule. Vaccine 2021; 9: 100115.

[23] Yingxiong W. A review of China's compensation program for adverse reactions following immunization. Front Public Health 2023; 11: 1211976.

[24] Miller IF, Metcalf CJE. Assessing the risk of vaccine-driven virulence evolution in SARS-CoV-2. R Soc Open Sci 2022; 9(1): 211021.

[25] Kuchar E, Karlikowska-Skwarnik M, Han S, Nitsch-Osuch A. Pertussis: History of the disease and current prevention failure. Adv Exp Med Biol 2016; 934: 77-82.

[26] Sharomi O, Xausa I, Nachbar R, Pillsbury M, Matthews I, Petigara T, et al. Modeling the impact of exogenous boosting and universal varicella vaccination on the clinical and economic burden of varicella and herpes zoster in a dynamic population for England and Wales. Vaccines (Basel) 2022; 10(9): 1416.

[27] Hardt K, Bonanni P, King S, Santos JI, El-Hodhod M, Zimet GD, et al. Vaccine strategies: Optimising outcomes. Vaccine 2016; 34(52): 6691-6699.

[28] Mina MJ. Measles, immune suppression and vaccination: Direct and indirect nonspecific vaccine benefits. J Infect 2017; 74(Suppl 1): S10-S17.

[29] Chumakov K, Ehrenfeld E, Agol VI, Wimmer E. Polio eradication at the crossroads. Lancet Glob Health 2021; 9(8): e1172-e1175.